# Phase 6 Completion & Reconciliation Report

**Authority Reference:** [`PROJECT_SPEC.md`](file:///d:/daa/PROJECT_SPEC.md) (§1.3, §18.3, §21.1–§21.7, §22.1–§22.3, §25 Phase 6, §26 Phase 6 Acceptance Criteria)  
**Parent Audits & Reports:**  
- [`PROJECT_SPEC_REQUIREMENTS_MATRIX.md`](file:///d:/daa/PROJECT_SPEC_REQUIREMENTS_MATRIX.md)  
- [`experiments/FINAL_PROJECT_RECONCILIATION_AUDIT.md`](file:///d:/daa/experiments/FINAL_PROJECT_RECONCILIATION_AUDIT.md)  
- [`experiments/FINAL_REPORT_DATA_SHEET.md`](file:///d:/daa/experiments/FINAL_REPORT_DATA_SHEET.md)  
- [`experiments/end-to-end-evaluation/REPORT.md`](file:///d:/daa/experiments/end-to-end-evaluation/REPORT.md)  
- [`experiments/end-to-end-evaluation/PHASE5_REMEDIATION_REPORT.md`](file:///d:/daa/experiments/end-to-end-evaluation/PHASE5_REMEDIATION_REPORT.md)  
- [`experiments/V10-ood-template-evaluation/REPORT.md`](file:///d:/daa/experiments/V10-ood-template-evaluation/REPORT.md)  
- [`experiments/V8-verification-cascade/V12_RISK_COVERAGE_ANALYSIS.md`](file:///d:/daa/experiments/V8-verification-cascade/V12_RISK_COVERAGE_ANALYSIS.md)  
- [`reports/PHASE2_RECONCILIATION_REPORT.md`](file:///d:/daa/reports/PHASE2_RECONCILIATION_REPORT.md)  
**Auditor:** Automated Engineering Integrity Agent (Antigravity)  
**Date:** 2026-10-03  
**Status:** **ACCEPTED — COMPLETE WITH DOCUMENTED LIMITATION**

---

## 1. Executive Summary

Phase 6 of the clinical document-to-EHR conversion and verification pipeline governs **End-to-End Pipeline Evaluation and Real-Data Slice Assessment** ([`PROJECT_SPEC.md`](file:///d:/daa/PROJECT_SPEC.md) §25, §26).

Prior to this audit, the Phase 6 Acceptance Gate (Item 116 in [`PROJECT_SPEC_REQUIREMENTS_MATRIX.md`](file:///d:/daa/PROJECT_SPEC_REQUIREMENTS_MATRIX.md)) was classified as `PARTIALLY COMPLETE` due to an unclosed documentation synthesis gap regarding the compound raw-document-to-FHIR scalar metric.

This audit establishes that all underlying technical, experimental, and empirical evaluation artifacts for Phase 6 are fully executed, verified, and frozen:
1. **End-to-End Pipeline Evaluation (§21.7):** Fully evaluated via the deterministic evaluator [`eval/evaluate_end_to_end.py`](file:///d:/daa/eval/evaluate_end_to_end.py), with results published across both tiers: historical baseline ([`eval/end_to_end_results.json`](file:///d:/daa/eval/end_to_end_results.json)) and remediated post-audit tier ([`eval/end_to_end_results_remediated.json`](file:///d:/daa/eval/end_to_end_results_remediated.json)).
2. **Comprehensive OOD Results (§21):** Every metric family in §21 possessing an Out-Of-Distribution (OOD) variant has complete, frozen OOD results on the canonical 34-document (1,826 claims) template-holdout benchmark.
3. **Real-Data Slice (§18.3, §23.2):** Formally tracked and explicitly documented as an acknowledged project limitation in [`n2c2_access/REQUEST_STATUS.md`](file:///d:/daa/n2c2_access/REQUEST_STATUS.md) and [`FINAL_REPORT_OUTLINE.md`](file:///d:/daa/FINAL_REPORT_OUTLINE.md) Section 30, directly satisfying the disjunctive acceptance criterion of §26.

**Final Verdict:** Phase 6 formal acceptance is certified as **`COMPLETE WITH DOCUMENTED LIMITATION`**.

---

## 2. Re-Audit of PROJECT_SPEC.md §26 Phase 6 Acceptance Criteria

The canonical acceptance specification in [`PROJECT_SPEC.md`](file:///d:/daa/PROJECT_SPEC.md) §26 defines three mandatory criteria for Phase 6 acceptance:

| # | Acceptance Criterion | Canonical Specification Language (§26) | Existing Repository Evidence / Findings | Compliance Status |
|---|:---|:---|:---|:---:|
| **1** | **End-to-End Accuracy Reported** | *"End-to-end accuracy reported"* (§21.7: fraction of ground-truth claims appearing in final bundle with correct value, correct code, and correct verification label). | **1. Deterministic Evaluator:** [`eval/evaluate_end_to_end.py`](file:///d:/daa/eval/evaluate_end_to_end.py) executed and machine-verified across all 1,826 OOD claims.<br>**2. Historical Baseline Tier:** 12.92% strict compound accuracy (236 / 1,826); 59.86% in-bundle verified value accuracy (1,093 / 1,826); 96.73% conditional in-bundle accuracy; 0.00% concept coding due to parameter omission.<br>**3. Remediated Tier:** 59.86% strict compound accuracy (1,093 / 1,826); 96.73% conditional in-bundle accuracy; 100.0% concept coding recovery (1,130 / 1,130).<br>**4. Document Breakdown:** Lab 58.72%, Med 60.80%, Narrative 67.70%. | **SATISFIED** |
| **2** | **OOD Results for Every Metric Family** | *"OOD results reported for every metric family in §21 that has an OOD variant"* | **1. Extraction (§21.1):** OOD reported in E4 (§5), E2 (§4), E3 (§4).<br>**2. Evidence Linking (§21.2):** Bboxes and offsets verified on OOD.<br>**3. Verification (§21.3):** V1–V6, V8, V9 evaluated on 1,826 OOD claims in [`experiments/V10-ood-template-evaluation/REPORT.md`](file:///d:/daa/experiments/V10-ood-template-evaluation/REPORT.md).<br>**4. FHIR Validity (§21.4):** 100% schema validity (0 errors) on 34 OOD bundles.<br>**5. Selective Prediction (§21.5):** Risk-coverage curve, AURC (0.0346 Stage B vs 0.0543 Cascade / 0.0069 risk at 79.13% coverage) in [`experiments/V8-verification-cascade/V12_RISK_COVERAGE_ANALYSIS.md`](file:///d:/daa/experiments/V8-verification-cascade/V12_RISK_COVERAGE_ANALYSIS.md).<br>**6. End-to-End (§21.7):** Evaluated on 34 OOD documents in [`experiments/end-to-end-evaluation/REPORT.md`](file:///d:/daa/experiments/end-to-end-evaluation/REPORT.md). | **SATISFIED** |
| **3** | **Real-Data Slice Disposition** | *"real-data slice either completed with a qualitative report or its absence explicitly documented as a limitation."* | **1. Feasibility-Gated Clause (§18.3):** Real data slice was explicitly conditioned on DUA credentialing timelines.<br>**2. Absence Explicitly Documented:** Formal limitation disclosures published in [`n2c2_access/REQUEST_STATUS.md`](file:///d:/daa/n2c2_access/REQUEST_STATUS.md), [`docs/decisions/DEC-010-real-data-dataset-selection.md`](file:///d:/daa/docs/decisions/DEC-010-real-data-dataset-selection.md), [`experiments/FINAL_PROJECT_RECONCILIATION_AUDIT.md`](file:///d:/daa/experiments/FINAL_PROJECT_RECONCILIATION_AUDIT.md) (Item 69, Section 10 Item 2), and [`FINAL_REPORT_OUTLINE.md`](file:///d:/daa/FINAL_REPORT_OUTLINE.md) Section 30. | **SATISFIED** |

---

## 3. Authoritative End-to-End Compound Evaluation Matrix (§21.7)

Below is the definitive, machine-verified comparison across both Phase 5 serialization tiers on the canonical 34-document Out-Of-Distribution (OOD) benchmark:

```
+-------------------------------------------------------------------------------------------------------------------------------+
|                                    COMPOUND END-TO-END PIPELINE METRIC RECONCILIATION (§21.7)                                  |
+--------------------------------------+---------------------------------------+------------------------------------------------+
| Metric Dimension                     | Historical Frozen Baseline Tier       | Remediated Post-Audit Tier                     |
|                                      | (`data/fhir_phase5_v8/`)              | (`data/fhir_phase5_v8_remediated/`)           |
+--------------------------------------+---------------------------------------+------------------------------------------------+
| **Evaluation Scope**                 | 34 OOD Documents (1,826 GT Claims)    | 34 OOD Documents (1,826 GT Claims)             |
| **Claims in Audit Reports**          | 1,826 / 1,826 (100.00%)               | 1,826 / 1,826 (100.00%)                        |
| **Claims in FHIR Resource Provenance**| 1,130 / 1,826 (61.88%)                | 1,130 / 1,826 (61.88%)                         |
| **Shadowed / Unmapped Entity Claims**| 696 / 1,826 (38.12%)                  | 696 / 1,826 (38.12%)                           |
| **Overall Verification Accuracy**    | **97.48%** (1,780 / 1,826)            | **97.48%** (1,780 / 1,826) [Bit-for-Bit Id]    |
| **In-Bundle Verified Value Accuracy**| **59.86%** (1,093 / 1,826)            | **59.86%** (1,093 / 1,826)                     |
| **Conditional In-Bundle Accuracy**   | **96.73%** (1,093 / 1,130)            | **96.73%** (1,093 / 1,130)                     |
| **Correct Value Representation**     | 1,130 / 1,130 (100.00%)               | 1,130 / 1,130 (100.00%)                        |
| **Concept Coding Rate (LOINC/RxNorm)**| **0.00%** (0 / 1,130)                 | **100.00%** (1,130 / 1,130)                    |
| **Strict §21.7 Compound Accuracy**   | **12.92%** (236 / 1,826 flags only)   | **59.86%** (1,093 / 1,826)                     |
| **Upstream-Joined Compound Accuracy**| **54.49%** (995 / 1,826)              | **54.49%** (995 / 1,826)                       |
+--------------------------------------+---------------------------------------+------------------------------------------------+
```

### Scientific Integrity Disclosure:
The increase in strict §21.7 compound accuracy from **12.92% to 59.86%** is attributable **exclusively to passing the recovered terminology parameters into the canonical FHIR mapper**, not to any modification of ML models, cascade thresholds, or prompt engineering. Both tiers are retained in the repository to maintain full scientific auditability.

---

## 4. Phase 6 Requirements Inventory & Status Classification

Every requirement assigned to or associated with Phase 6 across [`PROJECT_SPEC.md`](file:///d:/daa/PROJECT_SPEC.md) (§18.3, §21.7, §22.1–§22.3, §25, §26) is classified below:

| Req ID | Specification Reference | Subsystem / Requirement Description | Formal Category | Final Status | Justification / Proving Artifact |
|:---:|:---|:---|:---:|:---:|:---|
| **81** | §21.7 | Compound End-to-End Pipeline Metric | `MUST` | **`COMPLETE WITH DOCUMENTED LIMITATION`** | Evaluated and documented across both historical (12.92%) and remediated (59.86%) tiers in [`experiments/end-to-end-evaluation/REPORT.md`](file:///d:/daa/experiments/end-to-end-evaluation/REPORT.md). |
| **95** | §22.2, §22.3 | Experiment V9: Standalone Prompted Qwen-7B Verifier | `SHOULD` | **`COMPLETE`** | Evaluated on canonical 1,826 OOD claims (Macro-F1: 0.8543, Recall: 0.9755); persisted in [`experiments/V8-verification-cascade/V9_QWEN_ONLY_OOD_ANALYSIS.md`](file:///d:/daa/experiments/V8-verification-cascade/V9_QWEN_ONLY_OOD_ANALYSIS.md). |
| **69** | §18.3, §23.2 | Real-Data Qualitative Validation Slice (n2c2) | `SHOULD` | **`FEASIBILITY-GATED`** | Feasibility-gated due to DUA credentialing timeline; dropped per §18.3 with formal limitation documented in [`n2c2_access/REQUEST_STATUS.md`](file:///d:/daa/n2c2_access/REQUEST_STATUS.md). |
| **86** | §22.1, §22.3 | Experiment E5: Degradation Robustness Matrix | `SHOULD` | **`PARTIALLY COMPLETE`** | Evaluated on lab extraction across 7 visual and 3 text corruptions at 3 severities in [`data/benchmark_results/m1_robustness_report.json`](file:///d:/daa/data/benchmark_results/m1_robustness_report.json); med/narrative multi-extractor unexecuted. |
| **97** | §22.2, §22.3 | Experiment V11: Feature Ablation on V7 | `SHOULD` | **`NOT COMPLETE`** | Blocked by absence of V7 checkpoint. Designated as `SHOULD, optional if time-constrained` in §22.2. |
| **99** | §22.2, §22.3 | Experiment V13: LoRA-Fine-Tuned Small LLM Verifier | `OPTIONAL` | **`OPTIONAL / NOT REQUIRED`** | Explicitly marked `(OPTIONAL)` in §22.2 and §22.3. Unexecuted. |
| **116**| §25, §26 | Phase 6 Acceptance Gate | `MUST` | **`COMPLETE WITH DOCUMENTED LIMITATION`** | All three §26 acceptance criteria verified and closed with existing frozen artifacts and documented limitation statements. |

---

## 5. Scope Boundary Analysis & Remaining Genuine Gaps

### Genuine Gaps vs. Closed Requirements:
1. **Phase 6 Acceptance Gate (Item 116):** **CLOSED** as `COMPLETE WITH DOCUMENTED LIMITATION`. All three criteria in §26 are satisfied without running new ML inference.
2. **Experiment E5 (Degradation Robustness Across Extractors):** **REMAINS PARTIALLY COMPLETE**. E5 was completed for laboratory panels in M1 (`m1_robustness_report.json`), but full cross-evaluation of E1–E3 across medication and narrative forms was not executed. Per §22.3 and §25, this was a `SHOULD` experiment if time allowed, and is preserved as an acknowledged project limitation.
3. **Experiment V7 / V11 (OCR-Aware ModernBERT & Ablation):** **REMAINS NOT COMPLETE**. Blocked by GPU compute and training timeline limits. Not required for Phase 6 acceptance.
4. **Real-Data Validation Slice (n2c2 Track 2):** **REMAINS FEASIBILITY-GATED**. DUA credentialing timeline prevented processing external clinical notes. Fully satisfied under §26 via explicit limitation documentation.

### Experiments That MUST Still Be Executed:
**NONE.** No further machine learning training, fine-tuning, or inference experiments are required or permitted. All acceptance gates for Phases 0 through 6 are closed or formally documented.

---

## 6. Test Suite & Verification Results

The deterministic end-to-end evaluator and associated data-integrity test suites were executed:

```powershell
.venv\Scripts\python.exe eval/evaluate_end_to_end.py
.venv\Scripts\python.exe eval/evaluate_end_to_end.py data/fhir_phase5_v8_remediated
.venv\Scripts\pytest.exe tests/test_audit_report.py tests/test_canonical_fhir_mapping.py tests/test_m2_splits.py tests/test_m2_3way_splits.py
```

**Results:**
- **Deterministic End-to-End Evaluation:**
  - Historical Baseline: 100% of 1,826 OOD claims evaluated; compound accuracy verified at 12.92% (strict) / 59.86% (in-bundle value) / 96.73% (conditional in-bundle).
  - Remediated Tier: 100% of 1,826 OOD claims evaluated; compound accuracy verified at 59.86% (strict) / 96.73% (conditional in-bundle) / 100.0% concept coding recovery.
- **Pytest Suite:**
  - **41 / 41 tests passed** (100.0% pass rate in 21.93s).
  - Zero split leakage between CV and OOD partitions (`test_m2_splits.py`, `test_m2_3way_splits.py`).
  - 100% provenance extension population and audit report consistency (`test_audit_report.py`, `test_canonical_fhir_mapping.py`).

---

## 7. Phase 6 Formal Acceptance Sign-Off

All requirements and acceptance criteria for **Phase 6 — End-to-End Evaluation & Real-Data Slice** set forth in [`PROJECT_SPEC.md`](file:///d:/daa/PROJECT_SPEC.md) §25 and §26 have been empirically satisfied, machine-tested, and reconciled across project documentation.

Phase 6 is hereby certified as **COMPLETE WITH DOCUMENTED LIMITATION**.
